Quest Diagnostics Financial Ratios
NYSE: DGXHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Quest Diagnostics ratio analysis
Quest Diagnostics earned a net margin of 9.0% in FY 2025, up from 8.8% a year earlier. Gross margin was 33.2% compared with a median of 34.8% over the prior 9 years. Return on equity reached 13.8%, meaning Quest Diagnostics generated 0.14 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.79 versus 0.92 the year before, and the current ratio was 1.04. At the end of FY 2025, DGX traded at 19.9 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 11.1 to 20.4, with a median of 18.2. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Quest Diagnostics financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 19.86 | 19.76 | 18.41 | 19.63 | 11.13 | 11.38 | 16.74 | 15.64 | 17.91 | 20.38 |
| Price / sales | 1.75 | 1.71 | 1.67 | 1.84 | 2.00 | 1.69 | 1.82 | 1.49 | 1.82 | 1.78 |
| Price / book | 2.69 | 2.49 | 2.45 | 3.08 | 3.36 | 2.36 | 2.50 | 2.16 | 2.74 | 2.78 |
| Gross margin | 33.2% | 32.9% | 33.0% | 34.7% | 39.0% | 38.5% | 34.8% | 34.6% | 36.2% | 40.2% |
| Operating margin | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.7% | 17.7% |
| Net margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.4% | 8.9% |
| Free cash flow margin | 12.3% | 9.2% | 9.3% | 13.3% | 17.0% | 16.8% | 10.9% | 10.8% | 12.5% | 11.4% |
| Return on equity (ROE) | 13.8% | 12.9% | 13.5% | 16.1% | 31.0% | 21.2% | 15.2% | 14.1% | 15.7% | 13.9% |
| Return on assets (ROA) | 6.1% | 5.4% | 6.1% | 7.4% | 14.7% | 10.2% | 6.7% | 6.7% | 7.4% | 6.4% |
| Debt / equity | 0.79 | 0.92 | 0.75 | 0.68 | 0.62 | 0.59 | 0.85 | 0.75 | 0.77 | 0.81 |
| Current ratio | 1.04 | 1.10 | 1.31 | 1.22 | 1.56 | 1.72 | 1.25 | 0.94 | 1.24 | 1.56 |
| Revenue growth | 11.8% | 6.7% | -6.4% | -8.4% | 14.3% | 22.1% | 2.6% | 1.7% | 2.6% | -3.7% |
| EPS growth | 13.8% | 2.7% | -6.0% | -48.7% | 48.5% | 66.7% | 18.7% | -3.8% | 22.0% | -7.4% |